Noninvasive visualization of adenovirus replication with a fluorescent reporter in the E3 region

Hidetaka A Ono1, Long P Le, Julia G Davydova

  • 1Division of Human Gene Therapy, Department of Medicine, and the Gene Therapy Center, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.

Cancer Research
|November 17, 2005
PubMed

Insights

Researchers developed a novel adenovirus vector that uses enhanced green fluorescent protein (EGFP) to track tumor-specific viral replication. This noninvasive imaging method allows real-time monitoring of oncolytic adenovirus activity in vivo.

Area of Science:

  • Oncolytic virotherapy
  • Molecular imaging
  • Adenovirus engineering

Background:

  • Current cancer treatments have limitations, including inefficacy and side effects.
  • Conditionally replicative adenoviruses offer tumor-specific oncolysis.
  • Lack of noninvasive methods hinders understanding of in vivo adenovirus replication.

Purpose of the Study:

  • To develop a reporter system for noninvasive monitoring of adenovirus replication in vivo.
  • To assess the correlation between reporter expression and viral replication.

Main Methods:

  • Constructed adenovirus replication reporter vectors incorporating the enhanced green fluorescent protein (EGFP) gene in the E3 region.
  • Maintained expression of the adenovirus death protein to preserve oncolytic function.
  • Utilized fluorescence imaging and Western blot analysis to quantify viral replication and reporter expression.

Main Results:

  • EGFP fluorescence was detected in a replication-dependent manner, correlating with viral DNA replication.
  • In vivo fluorescence imaging successfully detected and monitored adenovirus replication noninvasively.
  • Reporter gene expression accurately reflected viral DNA replication levels in tumors.

Conclusions:

  • Adenovirus vectors expressing reporter genes provide a viable method for noninvasive monitoring of replication.
  • This approach enables real-time assessment of oncolytic adenovirus activity in preclinical studies.
  • The technology holds potential for clinical application with relevant imaging reporters.